Company Microbix Biosystems Inc.

Equities

MBX

CA59501P1045

Biotechnology & Medical Research

Market Closed - Toronto S.E. 19:04:48 21/06/2024 BST 5-day change 1st Jan Change
0.335 CAD 0.00% Intraday chart for Microbix Biosystems Inc. +3.08% -14.10%

Business Summary

Microbix Biosystems Inc. is a Canada-based life science company, which develops and commercializes biological and technological solutions for human health and wellbeing. The Company manufactures a wide range of critical biological materials for the global diagnostics industry, mainly antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. It operates through two segments: the development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and the development and commercialization of products or technologies such as Kinlytic. Its Kinlyti urokinase is a biologic thrombolytic drug used to treat blood clots.

Sales per Business

CAD in Million2022Weight2023Weight Delta
Antigens,Quality Assessment Products and DxTM
91.8 %
19 100.0 % 15 91.8 % -20.49%
Other (includes Kinlytic)
8.2 %
0 0.0 % 1 8.2 % +30,440.89%

Sales per region

CAD in Million2022Weight2023Weight Delta
North America
65.6 %
13 68.9 % 11 65.6 % -17.58%
Europe
34.4 %
6 31.0 % 6 34.4 % -4.05%
Other Foreign Countries
0.0 %
0 0.1 % 0 0.0 % -73.92%

Managers

Managers TitleAgeSince
Chief Executive Officer - 07/03/12
Director of Finance/CFO - 31/10/16
Chief Tech/Sci/R&D Officer - -
Compliance Officer 65 -
Chief Tech/Sci/R&D Officer - 31/12/94
Director/Board Member 66 05/02/07
Sales & Marketing - 31/12/02

Members of the board

Members of the board TitleAgeSince
Director/Board Member - 01/10/90
Director/Board Member - 05/12/05
Chief Executive Officer - 07/03/12
Director/Board Member - 24/02/03
Chairman - 16/02/09
Director/Board Member 66 05/02/07
Director/Board Member - 29/03/22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 136,793,718 117,457,898 ( 85.86 %) 0 85.86 %

Shareholders

NameEquities%Valuation
9,440,037 6.870 % 2 M $
3,643,704 2.652 % 848 983 $
2,645,500 1.925 % 616 402 $
1,666,704 1.213 % 388 342 $
1,215,000 0.8842 % 283 095 $
LDIC, Inc.
0.4217 %
579,500 0.4217 % 135 024 $
Next Edge Capital Corp.
0.4002 %
550,000 0.4002 % 128 150 $
549,277 0.3997 % 127 982 $
521,486 0.3795 % 121 506 $
455,000 0.3311 % 106 015 $

Company contact information

Microbix Biosystems, Inc.

265 Watline Avenue

L4Z 1P3, Mississauga

+

http://microbix.com
address Microbix Biosystems Inc.(MBX)
  1. Stock Market
  2. Equities
  3. MBX Stock
  4. Company Microbix Biosystems Inc.